Valneva SE ACT Pfd

(VNVLF)

By |

Profile

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes two vaccines for travellers; one for the prevention of Japanese encephalitis (IXIARO) and the second (DUKORAL) for the prevention of cholera and diarrhoea. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, and third-party products; Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; and Technologies and services which relates to services and inventions at a commercialization stage. The group is based in France and operates internationally.

Contact Information

Website: www.valneva.com
Email: investors.relations@vivalis.com
Main Phone: +33 478766101
Address: 70, rue Saint Jean de Dieu
Address 2: Gerland Plaza Techsud
City / Town: Lyon
Country: FRA
Postal Code: 69007

Issuer Information

Exchange: GREY
Employees: 433
$ 0.04 $ 0. (0.00%)
Last Price 0.04 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.04
Last Trade Volume 0 52 Wk Hi 0.08 52 Wk Low 0.04
Market Cap 713,469 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 17,836,719.00 EPS (TTM) N/A PE Ratio N/A Exchange Greys

News